A randomized, double-blind, placebo- controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants

American Journal of Perinatology

Volumn 26, Issue 3, 2009, Pages 235-246

  Aranda, Jacob V ^a,k   Clyman, Ronald ^b   Cox, Blair ^c   Van Overmeire, Bart ^d   Wozniak, Paul ^e   Sosenko, Ilene ^f   Carlo, Waldemar A ^g   Ward, Robert M ^h   Shalwitz, Robert ⁱ   Baggs, Geraldine ⁱ   Seth, Anand ⁱ   Darko, Laszlo ^j  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f JACKSON MEMORIAL HOSPITAL   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h UNIVERSITY OF UTAH HOSPITAL   (United States)

ⁱ ABBOTT LABORATORIES   (United States)

^j Farmacon IL Inc   (United States)

^k SUNY DOWNSTATE MEDICAL CENTER   (United States)

more..

Author keywords

Cyclooxygenase inhibitors; Ibuprofen; Patent ductus arteriosus; Premature newborn; Randomized clinical trial

Indexed keywords

IBUPROFEN LYSINE; PLACEBO;

ARTICLE; BODY WEIGHT; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG CONCENTRATION; ECHOCARDIOGRAPHY; FEMALE; FLUID INTAKE; GESTATIONAL AGE; HUMAN; LIVER FUNCTION; LOW BIRTH WEIGHT; LUNG DYSPLASIA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RETROLENTAL FIBROPLASIA;

DOUBLE-BLIND METHOD; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; LYSINE; MALE; TIME FACTORS; TREATMENT OUTCOME;

EID: 61449212974     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0028-1103515     Document Type: Article

References (48)

1. Hammerman C. Patent ductus arteriosus. Clin Perinatol 1995;22:457-477
2. Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987;111:749-754
3. Dudell GG, Gersony WM. Patent ductus arteriosus in neonates with severe respiratory distress syndrome. J Pediatr 1984;104:915-920
4. Rubaltelli FF, Dani C, Reali MF, et al. Acute neonatal respiratory distress in Italy: a one-year prospective study. Acta Paediatr 1998;87:1261-1268
5. Hammerman C, Kaplan M. Comparative tolerability of pharmacological treatment for patent ductus arteriosus. Drug Saf 2001;24:537-551
6. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000;343:728-730
7. Cotton RB, Stahlman MT, Bender HW, et al. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978;93:647-651
8. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects ofindomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906
9. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev 2003;(2):CD003745: DOI: 10.1002/14651858.CD003745
10. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2006;(3): CD000174. DOI: 10.1002/14651858.CD000174
11. Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus-a double-blind controlled study. J Pediatr 1981;98:137-145
12. Rennie JM, Doyle J, Cooke RW. Early administration of indomethacin to preterm infants. Arch Dis Child 1986;61:233-238
13. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus arterio- sus closure. J Pediatr 2000;136:330-337
14. Keller RL, Clyman RI. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics 2003;112(3 Pt 1):583-587
15. Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can J Physiol Pharmacol 1979;57: 825-831
16. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996;275:539-544
17. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed 1997;76: F179-184
18. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effect of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 1997;131: 549-554
19. Grosfeld JL, Kamman K, Gross K, et al. Comparative effects of indomethacin, prostaglandin E1 and ibuprofen on bowel ischemia. J Pediatr Surg 1983;18:738-742
20. Malcom DD, Segar JL, Robillard JE, Chemtob S. Indomethacin compromises hemodynamics during positive-pressure ventilation independently of prostanoids. J Appl Physiol 1993;74:1672-1678
21. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36-42
22. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubatelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-738
23. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;(1):CD004213. DOI: 10.1002/14651858.CD004213.pub2
24. Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomized, double-blind, placebo-controlled trial. Lancet 2004;364:1945-1949
25. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674-681
26. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007;196:147.e1-e8
27. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113-1121
28. Gonzalez A, Sosenko IR, Chandar J, et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 1996;128:470-478
29. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final data for 2005. National vital statistics reports; Vol. 56, No. 6. Hyattsville, MD: National Center for Health Statistics; 2007
30. Australian New Zealand Clinical Trials Registry. Targeting of treatment of the patent ductus arteriosus using early echocardiography (DETECT). ID#: ACTRN 12608000295347. Available at: http://www.anzctr.org.au/trial-view.aspx?ID= 82886. Accessed August 6, 2008
31. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971;58:403-417
32. Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr 1997;86:289-293
33. Bell MJ. Neonatal necrotizing enterocolitis. N Engl J Med 1978;298:281-282
34. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 2004;364: 1939-1944
35. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990;21:777-784
36. Dani C, Bertini G, Pezzati M, et al. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage among preterm infants: a multicenter, randomized study. Pediatrics
37. 2005;115:1529-1535
38. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994; 124:951-955
39. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-534
40. Barkovich AJ, ed. Pediatric Neuroimaging. 3rd Ed. Philadelphia: Lippincott Williams and Wilkins; 2000:180-4
41. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135-140
42. Romagnoli C, De Carolis MP, Papacci P, et al. Effects of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin Pharmacol Ther 2000;67:676- 683
43. Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359:1486-1488
44. Hasan J, Beharry K, Gharraee Z, et al. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 2008;85:81-88
45. Schmidt B, Roberts R, Davis P, et al. The International Caffeine for Apnea of Prematurity (CAP) Trial. Preliminary analysis of outcome at corrected age of 18 to 21 months. Pediatric Academic Societies Meeting; May 5, 2007. Abstract 5130.1, Toronto, Canada
46. Kinsella JP, Cutter GR, Walsh WF, et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006;355:354-364
47. Edwards AD, Tan S. Perinatal infections, prematurity and brain injury. Curr Opin Pediatr 2006;18:119-124
48. Dammann O, Leviton A. Inflammation, brain damage and visual dysfunction in preterm infants. Semin Fetal Neonatal Med 2006;11:363-368